In this study, we measured the extent of STAT5 and STAT1 activation, proliferative capacity and cytokine production in different peripheral blood lymphocyte subsets from a group of patients with metastatic melanoma in comparison to a cohort of healthy controls upon HD IL-2 stimulation. This evidence concerns the gene STAT1 and metastatic melanoma.